378 filings
Page 6 of 19
6-K
BNTX
BioNTech SE
5 Aug 22
BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
6:49am
6-K
BNTX
BioNTech SE
27 Jul 22
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
6:55am
6-K
BNTX
BioNTech SE
25 Jul 22
Current report (foreign)
5:59pm
6-K
BNTX
BioNTech SE
19 Jul 22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Adapted Bivalent Vaccine Candidate
5:12pm
6-K
BNTX
BioNTech SE
8 Jul 22
Current report (foreign)
5:36pm
6-K
BNTX
BioNTech SE
8 Jul 22
Pfizer and BioNTech Announce U.S. FDA Approval of their COVID-19 Vaccine COMIRNATY® For Adolescents 12 through 15 Years of Age
5:23pm
6-K
BNTX
BioNTech SE
5 Jul 22
Statement on Patent Infringement Lawsuit in Germany
8:14pm
6-K
BNTX
BioNTech SE
29 Jun 22
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
6:36pm
6-K
BNTX
BioNTech SE
29 Jun 22
Current report (foreign)
6:27pm
6-K
BNTX
BioNTech SE
27 Jun 22
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
7:25am
6-K
BNTX
BioNTech SE
23 Jun 22
BioNTech Receives Priority Medicines (PRIME) Designation from EMA for Enhanced Regulatory Support of CAR-T Candidate BNT211 in Testicular Cancer
4:34pm
6-K
BNTX
BioNTech SE
17 Jun 22
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
5:59pm
6-K
BNTX
BioNTech SE
15 Jun 22
Pfizer and BioNTech Provide Update on Rolling Submission to European Medicines Agency for a Potential Variant-Adapted Vaccine
6:13pm
6-K
BNTX
BioNTech SE
6 Jun 22
Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO
6:10am
6-K
BNTX
BioNTech SE
1 Jun 22
Voting Results from BioNTech’s Annual General Meeting 2022
7:01pm
6-K
BNTX
BioNTech SE
23 May 22
Current report (foreign)
8:48am
6-K
BNTX
BioNTech SE
17 May 22
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
5:13pm
6-K
BNTX
BioNTech SE
16 May 22
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
7:48am
6-K
BNTX
BioNTech SE
12 May 22
Current report (foreign)
5:18pm
6-K
BNTX
BioNTech SE
9 May 22
Unaudited Interim Condensed Consolidated Financial Statements
7:05am